Counterfeit medicines are a global public health risk. We assess counterfeit reports involving the legitimate supply chain using 2009–2011 data from the Pharmaceutical Security Institute Counterfeit Incident System (PSI CIS) database that uses both open and nonpublic data sources. Of the 1,510 identified CIS reports involving counterfeits, 27.6% reported China as the source country of the incident/detection. Further, 51.3% were reported as counterfeit but the specific counterfeit subcategory was not known or verifiable. The most prevalent therapeutic category was anti-infectives (21.1%) with most reports originating from health-related government agencies. Geographically, Asian and Latin American regions and, economically, middle-income markets were most represented. A total of 127 (64.8%) of a total of 196 countries had no legitimate supply chain CIS counterfeit reports. Improvements in surveillance, including detection of security breaches, data collection, analysis, and dissemination are urgently needed to address public health needs to combat the global counterfeit medicines trade. (Más)
AFP Falsa Viagra China |
"En este sentido, el pasado mes de febrero, la Agencia Española del Medicamento lanzó la campaña No compres medicamentos en webs ilegales. Es un error fatal para tu salud, que tiene como objetivo concienciar a los ciudadanos sobre los riesgos de esta práctica. La iniciativa desaconseja seguir las ofertas de fármacos que a menudo se reciben a través del correo electrónico y recuerda que «más de la mitad de los medicamentos que circulan a través de la Red son falsificaciones fabricadas sin garantías a partir de sustancias no autorizadas, de baja calidad o con efectos tóxicos, que pueden producir daños irreparables a la salud"
La amenaza de los fármacos falsos
CRISTINA G. LUCIO 21.04.2015
Ver también:
No hay comentarios:
Publicar un comentario